174 related articles for article (PubMed ID: 19475691)
1. Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.
Longato L; de la Monte S; Kuzushita N; Horimoto M; Rogers AB; Slagle BL; Wands JR
Hepatology; 2009 Jun; 49(6):1935-43. PubMed ID: 19475691
[TBL] [Abstract][Full Text] [Related]
2. Synergistic premalignant effects of chronic ethanol exposure and insulin receptor substrate-1 overexpression in liver.
Longato L; de la Monte S; Califano S; Wands JR
Hepatol Res; 2008 Sep; 38(9):940-53. PubMed ID: 18336544
[TBL] [Abstract][Full Text] [Related]
3. Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
de la Monte SM; Tamaki S; Cantarini MC; Ince N; Wiedmann M; Carter JJ; Lahousse SA; Califano S; Maeda T; Ueno T; D'Errico A; Trevisani F; Wands JR
J Hepatol; 2006 May; 44(5):971-83. PubMed ID: 16564107
[TBL] [Abstract][Full Text] [Related]
4. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
5. Activation of signal transduction pathways during hepatic oncogenesis.
Chung W; Kim M; de la Monte S; Longato L; Carlson R; Slagle BL; Dong X; Wands JR
Cancer Lett; 2016 Jan; 370(1):1-9. PubMed ID: 26433160
[TBL] [Abstract][Full Text] [Related]
6. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
Tanaka S; Ito T; Wands JR
J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
[TBL] [Abstract][Full Text] [Related]
8. Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
Mohr L; Banerjee K; Kleinschmidt M; Bartolomé Rodríguez MM; Wands JR
Hepatol Res; 2008 Dec; 38(12):1233-40. PubMed ID: 18631251
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
Merle P; Kim M; Herrmann M; Gupte A; Lefrançois L; Califano S; Trépo C; Tanaka S; Vitvitski L; de la Monte S; Wands JR
J Hepatol; 2005 Nov; 43(5):854-62. PubMed ID: 16098625
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver.
Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP
Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954
[TBL] [Abstract][Full Text] [Related]
11. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
13. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
[TBL] [Abstract][Full Text] [Related]
14. Ethanol inhibition of insulin signaling in hepatocellular carcinoma cells.
Banerjee K; Mohr L; Wands JR; de la Monte SM
Alcohol Clin Exp Res; 1998 Dec; 22(9):2093-101. PubMed ID: 9884156
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells.
Ahodantin J; Lekbaby B; Bou Nader M; Soussan P; Kremsdorf D
Carcinogenesis; 2020 May; 41(3):358-367. PubMed ID: 31175830
[TBL] [Abstract][Full Text] [Related]
16. Activation of Wnt/β-catenin signaling restores insulin sensitivity in insulin resistant neurons through transcriptional regulation of IRS-1.
Tian S; Tan S; Jia W; Zhao J; Sun X
J Neurochem; 2021 May; 157(3):467-478. PubMed ID: 33336396
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
18. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Cantarini MC; de la Monte SM; Pang M; Tong M; D'Errico A; Trevisani F; Wands JR
Hepatology; 2006 Aug; 44(2):446-57. PubMed ID: 16871543
[TBL] [Abstract][Full Text] [Related]
19. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
